Community/Retail

Early intervention by pharmacists can help stave off condition's serious consequences.

Dennis O’Neill, president and board member of BIOMEDICAN, discusses the current field of research assessing biosynthesis therapeutics that use psychedelics and rare cannabinoids.

Individuals with COVID-19 who had not had a flu shot were up to 20% more likely to be admitted to the ICU and were up to 58% more likely to visit the emergency department.

The cause of the issue is being further investigated, which is limited to certain aerosol sunscreen products based on the samples.

A huge cost savings could be generated with the success of a hepatitis C vaccine.

As COVID-19 vaccination efforts continue, it is more important than ever for pharmacists to be equipped with the knowledge and resources to bust the myths surrounding vaccinations, particularly in preparation for the upcoming influenza season, which is expected to occur from October 2021 to May 2022.

Ten quiz questions to assess your knowledge on common hypertension treatments.

Vaccinated individuals overall had large amounts of antibodies present compared to infected individuals, suggesting that vaccination both protects against becoming infected and reduces the likelihood of transmitting the virus to others.

Individuals with at least one inactive copy of the gene have lower BMIs and, on average, face a 54% lower risk of obesity than individuals without the mutations.

Pharmacists who are proactive—in other words, taking account of the environment and being able to foresee health systems and patients’ needs ahead of time—are more effective in promoting practice change.

In an interview with Pharmacy Times, Chris Zaleski, PharmD, RPh, said pharmacy technicians are essential pharmacy team members to prevent dispensing errors and enhance patient care.

Pharmacies that received more than $750,000 in federal funds, including funds from the CARES Act Provider Relief Fund, will be subject to single audit requirements.

The researchers also tested the effectiveness of 2 different transmission control strategies.

Patients may consult with their pharmacist regarding appropriate protection methods and treatment options available for common summer skin ailments.

The study plans to enroll approximately 180 participants to evaluate the safety, reactogenicity, and immunogenicity of its quadrivalent seasonal influenza mRNA vaccine in adults 18 years and older.

The risk for developing the rare neurological condition are low following vaccination, with the FDA noting the benefits of vaccination far outweigh the potential risks.

The FDA also granted Breakthrough Therapy Designation to tezepelumab for patients with severe asthma without an eosinophilic phenotype in September 2018.

According to the investigators, gene changes unique among individuals who responded to mirikizumab indicate that mirikizumab affects a distinct molecular healing pathway when compared to the spontaneous healing that occurred among the cohort administered the placebo.

No significant differences were found in blood pressure, blood sugar levels, or kidney function when comparing both medications among patients with type 2 diabetes.

Researchers hypothesized that people may look for the UV-B type of UV light because they are unaware of their need for endorphins.

There seems to be a growing divergence of messages in the marketplace on how the pharmacy benefit is valued.

The companies say COVID-19 booster shots may be necessary, although the FDA and CDC have disagreed.

Although pharmaceutical companies have already begun developing COVID-19 vaccine boosters, Michael Haydock of Informa Pharma Intelligence said boosters may not be necessary in the fall of 2021.

The preprint submitted by the company consists of a new analysis from blood samples obtained from a subset of participants in the phase 3 ENSEMBLE study.

The new results add to earlier findings from the EMPEROR-Reduced phase 3 trial, which found that empagliflozin reduced the combined relative risk of cardiovascular death or hospitalization for heart failure by 25% compared to placebo.

A retrospective case series published in JAMA Cardiology found that although there are rare instances of myocarditis—inflammation of the heart muscle—in younger men following COVID-19 vaccination, the greater risk for heart damage and death comes from COVID-19 infection.

The investigators also found that the risk of spreading disease may be lower amongst those with breakthrough infections.

The messages offered alternatives to these prescription drugs and offered education for providers that is designed to lead to a change in medication.

The updated label follows controversy surrounding aducanumab’s approval in June 2021, despite hesitation from experts on the drug’s efficacy.